vimarsana.com

Latest Breaking News On - Roivant sciences price performance - Page 1 : vimarsana.com

Roivant Sciences Ltd (NASDAQ:ROIV) Receives Consensus Rating of Moderate Buy from Brokerages

Shares of Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) have been given an average rating of “Moderate Buy” by the ten research firms that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. […]

HC Wainwright Reaffirms Buy Rating for Roivant Sciences (NASDAQ:ROIV)

Roivant Sciences (NASDAQ:ROIV – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a report issued on Monday, Benzinga reports. They presently have a $18.00 target price on the stock. HC Wainwright’s price target indicates a potential upside of 64.53% from the company’s previous close. Other research analysts […]

Roivant Sciences Sees Unusually High Options Volume (NASDAQ:ROIV)

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) was the recipient of some unusual options trading on Tuesday. Investors acquired 8,333 call options on the company. This represents an increase of 169% compared to the average volume of 3,098 call options. Wall Street Analysts Forecast Growth Several research firms recently issued reports on ROIV. JPMorgan […]

Edge Wealth Management LLC Sells 41,004 Shares of Roivant Sciences Ltd (NASDAQ:ROIV)

Edge Wealth Management LLC reduced its stake in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 23.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 134,528 shares of the company’s stock after selling 41,004 shares during the period. Edge Wealth Management LLC’s holdings […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.